2024
|
Invention
|
Sterile or sterilized package for administration of medicinal or nutritional substances.
A packa... |
|
Invention
|
Treatment of primary ctla-4 checkpoint related immunodeficiencies with 1h-indole-3-carboxaldehyde... |
2022
|
Invention
|
Multi chamber flexible bag and methods of using same. A method of preparing a pharmaceutical prod... |
2021
|
P/S
|
Pharmaceutical preparations for treatment of cancer and pharmaceutical conditioning regimen consi... |
|
P/S
|
Pharmaceutical preparations; Pharmaceutical preparations for treatment of cancer and pharmaceutic... |
2020
|
Invention
|
Multi chamber flexible bag and methods of using same.
A method of preparing a pharmaceutical pro... |
|
Invention
|
Sterile and sterilized package for administration of medicinal or nutritional substances. A packa... |
|
Invention
|
Sterile or sterilized package for administration of medicinal or nutritional substances. A packag... |
2019
|
Invention
|
Sterile flexible package with pressure compensator for the dosed reconstitution of fluid medicina... |
2017
|
Invention
|
Multi chamber flexible bag and methods of using the same. A method of preparing a pharmaceutical ... |
2016
|
Invention
|
Sterilizable flexible package for the reconstitution and administration of fluid medicinal or nut... |
|
Invention
|
Methods of treating aplastic anemia by administering anti-cd26 antibodies. The present invention ... |
2015
|
Invention
|
Flexible package with a sealed sterile chamber for the reconsitution and administration of fluid ... |
|
Invention
|
Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression... |
2014
|
Invention
|
Indole-3-aldehyde for treating dysreactive immune disorders. The therapeutic use of bacteria, spe... |
|
Invention
|
Artificial dna sequence with optimized leader function in 5′(5′-utr) for the over-expression of r... |
|
Invention
|
Artificial dna sequence with optimized leader function in 5' (5'-utr) for the over-expression of ... |
2007
|
Invention
|
Artificial dna sequence with optimized leader function in 5′ (5′-utr) for the improved expression... |